相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
Sara Bolivar-Wagers et al.
JCI INSIGHT (2022)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology
Geoffrey R. Hill et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Benjamin Watkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler et al.
BLOOD (2021)
Itacitinib prevents xenogeneic GVHD in humanized mice
Justine Courtois et al.
BONE MARROW TRANSPLANTATION (2021)
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tuning the Antigen Density Requirement for CAR T-cell Activity
Robbie G. Majzner et al.
CANCER DISCOVERY (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease
Bishwas Shrestha et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
Mark A. Schroeder et al.
BLOOD ADVANCES (2020)
Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody
Ziduo Li et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib
Laure Ricard et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
Rita Kansal et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Yaya Chu et al.
ONCOIMMUNOLOGY (2019)
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K. Srinagesh et al.
BLOOD ADVANCES (2019)
Circulating monocyte subsets in human chronic graft-versus-host disease
Takaaki Konuma et al.
BONE MARROW TRANSPLANTATION (2018)
Regulation of age-associated B cells by IRF5 in systemic autoimmunity
Michela Manni et al.
NATURE IMMUNOLOGY (2018)
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C. Betts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
From proteomics to discovery of first-in-class ST2 inhibitors active in vivo
Abdulraouf M. Ramadan et al.
JCI INSIGHT (2018)
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versushost disease
Ruishu Deng et al.
NATURE COMMUNICATIONS (2017)
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos et al.
BLOOD (2017)
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
Jonathan C. Poe et al.
BLOOD (2017)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
Circulating T follicular helper cells with increased function during chronic graft-versus-host disease
Edouard Forcade et al.
BLOOD (2016)
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn et al.
BLOOD (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Nicolaus Kroeger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings
Jonathan M. Weiss et al.
SCIENCE SIGNALING (2016)
ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings
Jonathan M. Weiss et al.
SCIENCE SIGNALING (2016)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
Ryan Flynn et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
Saar Gill et al.
BLOOD (2014)
CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
PLOS ONE (2013)
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan et al.
BLOOD (2012)
Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen
Brian C. Betts et al.
BLOOD (2011)
Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
Animesh Pardanani et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos et al.
BLOOD (2009)
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
John Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production
D Breitfeld et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function
P Schaerli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
T Miyamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
